Clinical Trials on Patients With Cicatricial Ectropion in Sweden
Total 10 results
-
Health NavigatorVastra Gotaland Region; Region Stockholm; Ostergotland County Council, Sweden; Uppsala...UnknownThe Focus is to Investigate Effects of a Disease Management Intervention for Patients With Congestive Heart FailureSweden
-
Karolinska University HospitalCompletedThe Value of Procalcitonin in Patients With Suspected CandidemiaSweden
-
Lund University HospitalActive, not recruitingTumor in Upper Gastrointestinal Canal or Patients With Colorectal CancerSweden
-
AstraZenecaTerminatedStroke Prevention in Patients With Atrial FibrillationSweden, Norway, Poland, United Kingdom, Finland, Denmark, United States, Czech Republic, Belgium
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Solvay PharmaceuticalsCompletedPatients With Metabolic SyndromeHungary, Canada, Finland, Italy, Netherlands, Norway, Poland, Romania, Sweden
-
H. Lundbeck A/STerminatedDepression in Patients With Bipolar DisorderAustria, Philippines, Australia, Belgium, Bulgaria, Canada, France, Germany, Korea, Republic of, Lithuania, Malaysia, Poland, Romania, Slovakia, Sweden, Taiwan, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedHyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement TherapyGermany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia